A defense, regulatory and registered patent attorney with experience as a registered pharmacist, Lee Rosebush counsels companies and executives as a strategic business advisor and serves as outside general counsel for pharmaceutical and pharmacy industry clients. His in-depth industry knowledge and experience working with biologics, medical device and healthcare companies gives clients a single source for regulatory, diligence and litigation counsel. Clients reach out to Lee as the first point of contact when confronted with legal issues related to development, operations, investment, marketing, advertising or product promotion.
With post-graduate degrees in finance and business, Lee is frequently sought out to help expedite corporate deals involving healthcare entities. He also advises private equity and public and private companies in due diligence matters and buy-sell transactions.
Lee's ability to smoothly shift between the legal, governmental and pharmaceutical environments further helps him to efficiently secure operating licenses or assist drug manufacturers avoid compliance actions from governmental agencies. Active with the Drug Quality and Security Act (DQSA), as well as the Federal Food and Drug Administration's (FDA) regulation of pharmacy compounding, Lee speaks and writes on both issues, and is passionate about orchestrating and advocating for pharmacists and pharmacies. He was recently named an Affiliate Professor at the University of Maryland School of Pharmacy. Additionally, Lee is Leader of BakerHostetler's Pharmacy and Reimbursement team and Co-Leader of the FDA, Products Promotion, and Defense team.